| pubmed-article:15949725 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C0024128 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:15949725 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:15949725 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15949725 | pubmed:dateCreated | 2005-6-13 | lld:pubmed |
| pubmed-article:15949725 | pubmed:abstractText | The majority of cyclosporine-treated transplant recipients develop hypertension. Endothelin-1 (ET-1) has been suggested to mediate cyclosporine-induced vasoconstriction when binding to ET-A receptors. We hypothesized that cyclosporine-treated lung transplant recipients have an increased basal vascular resistance and an augmented response to ET-A receptor blockade. | lld:pubmed |
| pubmed-article:15949725 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15949725 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949725 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15949725 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15949725 | pubmed:issn | 1053-2498 | lld:pubmed |
| pubmed-article:15949725 | pubmed:author | pubmed-author:FribergPeterP | lld:pubmed |
| pubmed-article:15949725 | pubmed:author | pubmed-author:JeppssonAnder... | lld:pubmed |
| pubmed-article:15949725 | pubmed:author | pubmed-author:AmbringAnneli... | lld:pubmed |
| pubmed-article:15949725 | pubmed:author | pubmed-author:NilssonFolkeF | lld:pubmed |
| pubmed-article:15949725 | pubmed:author | pubmed-author:SilverbornMar... | lld:pubmed |
| pubmed-article:15949725 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15949725 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:15949725 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15949725 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15949725 | pubmed:pagination | 665-70 | lld:pubmed |
| pubmed-article:15949725 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:meshHeading | pubmed-meshheading:15949725... | lld:pubmed |
| pubmed-article:15949725 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15949725 | pubmed:articleTitle | Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients. | lld:pubmed |
| pubmed-article:15949725 | pubmed:affiliation | Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. | lld:pubmed |
| pubmed-article:15949725 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15949725 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15949725 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:15949725 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
